Results 231 to 240 of about 32,113 (291)

Beyond the liver protective efficacy of silymarin; bright renoprotective effect on diabetic kidney disease. [PDF]

, 2014
Amiri, Masoud., Dehghani, Nahid., Kiani, Fereshte., Motamedi, Parisa., Nasri, Hamid., Nasri, Parto., Taheri, Zahra., Torkamaneh, Sara., Vakili, Leila.   +8 more
core  

Size-Controlled Mesoporous Silica Nanoparticles via Template Nanoarchitectonics from a Deferoxamine Derivative for Enhanced Blood-Brain Barrier Permeability and Neuroprotective Chelation Therapy. [PDF]

ACS Appl Mater Interfaces
Onrubia-Márquez M, Navas F, Sánchez-Carnerero EM, Martín A, Liturri A, Miciaccia M, Sanz R, Scilimati A, García-Muñoz RA, Perrone MG, Morales V.   +10 more
europepmc   +1 more source

Therapeutic targeting of the hepcidin-ferroportin axis and erythropoietic modulators: a narrative review. [PDF]

Front Med (Lausanne)
Mansour GK, Hajjar AW, Sajid MR.
europepmc   +1 more source

27-Hydroxycholesterol triggers microglial senescence subsequent to iron over-loading contributes to brain aging, suppressed by Deferoxamine. [PDF]

NPJ Aging
Yu C, Wang W, Shi L, Ma R, Zhang Y, Zhang C, Wang X, Wang T, Zheng Y, Tian J.   +9 more
europepmc   +1 more source

How bad can vision get in beta-thalassemia? A case report and review of the literature. [PDF]

BMC Ophthalmol
Azimi A, Zia Z.
europepmc   +1 more source

Ferroptotic resistance involved in PTEN-loss prostate cancer progression. [PDF]

Discov Oncol
Jing Y, Xing D, Zhao Z, Wang X.
europepmc   +1 more source

Retraction Note: Prophylactic treatment with transdermal deferoxamine mitigates radiation-induced skin fibrosis. [PDF]

Sci Rep
Shen AH, Borrelli MR, Adem S, Deleon NMD, Patel RA, Mascharak S, Yen SJ, Sun BY, Taylor WL, Januszyk M, Nguyen DH, Momeni A, Gurtner GC, Longaker MT, Wan DC.   +14 more
europepmc   +1 more source

Brain Glucose Hypometabolism and Brain Iron Accumulation as Therapeutic Targets for Alzheimer's Disease and Other CNS Disorders. [PDF]

Pharmaceuticals (Basel)
Rao IY, Hanson LR, Frey Ii WH.
europepmc   +1 more source

Deferoxamine as Zr(IV) Chelator: the K to Understanding.

, 2018
Matteo Savastano, Carla Bazzicalupi, Antonio Bianchi   +2 more
openalex   +1 more source